SHH and breast cancer: The remainder of this review is dedicated to summarizing the pertinent functions of tGLI1-mediated SHH signaling in glioblastoma and breast cancer (Figure 3), two cancers in which tGLI1 activity has been validated, and how tGLI1 activity can be leveraged to devise novel treatments.